Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its... see more

CSE:VTAL - Post Discussion

Justera Health Ltd > Good News ....maybe?
View:
Post by Smokey1958 on Feb 15, 2022 8:50pm

Good News ....maybe?

Imho the announcement today should be considered neutral to positive. It is arguably neutral because (a) the sp is what it is and (b) Andrew Ryu, right or wrong, has a much more demonstrable interest in Datametrex than in ScreenPro.

It certainly has the potential to be positive because (a) the sp can only go up and (b) new outside blood in the CEO chair working with Lena could very well accelerate expansion away from covid testing only. The new director, an advisor to Datametrex has a substantial resume so he too may look at this as an opportunity to take a young company to the next level. Of course he is likely the conduit between DM and SCRN as relates to covid testing.

I certainly like the idea of a management team that has little more autonomy from DM then it did yesterday.
Comment by bohemian62 on Feb 15, 2022 10:04pm
This is great news . The addition of the new appointments can only benefit SCRN . Having Mr. Ryu move on is a step in the right direction . I was not able to find much about Mr. Michael Yeung credentials but Mr. Charles Schade's are impressive and hopefully will positively contibute to SCRN  success . Charles Schade Linkedin  Market Research executive with 25 years’ experience ...more  
Comment by MyAli4s on Feb 16, 2022 6:51am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities